PTC Therapeutics (NASDAQ:PTCT) just reported results for the first quarter of 2024.
- PTC Therapeutics reported earnings per share of -$1.20. This was above the analyst estimate for EPS of -$1.24.
- The company reported revenue of $210.12 million.
- This was 23.82% better than the analyst estimate for revenue of $169.70 million.